Trial · NCT01464697
Results by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 48
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Vasomotor Symptoms (VMS)/ VMS Score - at 12 Weeks | Oral Micronized Progesterone | 5.5 | Standard Deviation 8.2 | Units of Vasomotor Symptom Score | |
| Vasomotor Symptoms (VMS)/ VMS Score - at 12 Weeks | Placebo Comparator | 7.1 | Standard Deviation 10.4 | Units of Vasomotor Symptom Score | |
| Frequency of VMS | Oral Micronized Progesterone | 2.4 | Standard Deviation 2.7 | episodes per day | |
| Frequency of VMS | Placebo Comparator | 3.0 | Standard Deviation 3.7 | episodes per day | |
| Severity of VMS | Oral Micronized Progesterone | 1.4 | Standard Deviation 1.0 | Units on a Scale of 0-4 | |
| Severity of VMS | Placebo Comparator | 1.5 | Standard Deviation 1.0 | Units on a Scale of 0-4 | |
| VMS Score by Early Perimenopause | Oral Micronized Progesterone | 4.4 | Standard Deviation 7.4 | Units of Vasomotor Symptom Score | |
| VMS Score by Early Perimenopause | Placebo Comparator | 3.9 | Standard Deviation 4.0 | Units of Vasomotor Symptom Score | |
| VMS Score by Late Perimenopause | Oral Micronized Progesterone | 5.9 | Standard Deviation 8.5 | Units of Vasomotor Symptom Score | |
| VMS Score by Late Perimenopause | Placebo Comparator | 8.8 | Standard Deviation 12.3 | Units of Vasomotor Symptom Score | |
| Subgroup Analysis for Those With Frequent and Severe VMS - VMS Score | Oral Micronized Progesterone | 11.8 | Standard Deviation 9.0 | Units of Vasomotor Symptom Score | |
| Subgroup Analysis for Those With Frequent and Severe VMS - VMS Score | Placebo Comparator | 15.1 | Standard Deviation 17.1 | Units of Vasomotor Symptom Score | |
| Sleep Problems | Oral Micronized Progesterone | 0.8 | Standard Deviation 0.8 | Units on a ordinal Scale | |
| Sleep Problems | Placebo Comparator | 1.0 | Standard Deviation 0.9 | Units on a ordinal Scale | |
| Anxiety | Oral Micronized Progesterone | 0.5 | Standard Deviation 0.6 | Units on a ordinal Scale | |
| Anxiety | Placebo Comparator | 0.6 | Standard Deviation 0.8 | Units on a ordinal Scale | |
| Women's Perceived Changes in Daytime Hot Flushes for Whole Population | Oral Micronized Progesterone | -2.3 | Standard Deviation 2.3 | Change Scale -5 to +5, no change is 0 | |
| Women's Perceived Changes in Daytime Hot Flushes for Whole Population | Placebo Comparator | -1.8 | Standard Deviation 2.3 | Change Scale -5 to +5, no change is 0 | |
| Women's Perceived Changes in Night Sweats for Whole Population | Oral Micronized Progesterone | -2.5 | Standard Deviation 2.0 | Change Scale -5 to +5, no change is 0 | |
| Women's Perceived Changes in Night Sweats for Whole Population | Placebo Comparator | -1.9 | Standard Deviation 2.0 | Change Scale -5 to +5, no change is 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01464697/results